Creative Planning’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,214
| Closed | -$57.9K | – | 3031 |
|
|
2024
Q1 | $57.9K | Hold |
24,214
| – | – | ﹤0.01% | 2752 |
|
|
2023
Q4 | $40.2K | Buy |
24,214
+4,000
| +20% | +$6.64K | ﹤0.01% | 2644 |
|
|
2023
Q3 | $38.8K | Sell |
20,214
-834
| -4% | -$1.6K | ﹤0.01% | 2494 |
|
|
2023
Q2 | $30.3K | Hold |
21,048
| – | – | ﹤0.01% | 2453 |
|
|
2023
Q1 | $44.2K | Hold |
21,048
| – | – | ﹤0.01% | 2339 |
|
|
2022
Q4 | $23.8K | Hold |
21,048
| – | – | ﹤0.01% | 2278 |
|
|
2022
Q3 | $34K | Hold |
21,048
| – | – | ﹤0.01% | 2116 |
|
|
2022
Q2 | $28K | Hold |
21,048
| – | – | ﹤0.01% | 2077 |
|
|
2022
Q1 | $34K | Buy |
21,048
+10,000
| +91% | +$16.2K | ﹤0.01% | 2078 |
|
|
2021
Q4 | $23K | Buy |
+11,048
| New | +$23K | ﹤0.01% | 2034 |
|
|
2017
Q3 | – | Sell |
-1,150
| Closed | -$3K | – | 2515 |
|
|
2017
Q2 | $3K | Buy |
1,150
+1,000
| +667% | +$2.61K | ﹤0.01% | 4104 |
|
|
2017
Q1 | $0 | Sell |
150
-338
| -69% | – | ﹤0.01% | 4558 |
|
|
2016
Q4 | $0 | Buy |
488
+338
| +225% | – | ﹤0.01% | 4484 |
|
|
2016
Q3 | $0 | Hold |
150
| – | – | ﹤0.01% | 4420 |
|
|
2016
Q2 | $0 | Hold |
150
| – | – | ﹤0.01% | 4244 |
|
|
2016
Q1 | $0 | Hold |
150
| – | – | ﹤0.01% | 4262 |
|
|
2015
Q4 | $0 | Sell |
150
-7,667
| -98% | – | ﹤0.01% | 4316 |
|
|
2015
Q3 | $18K | Buy |
+7,817
| New | +$18K | ﹤0.01% | 2777 |
|
|
2015
Q2 | – | Sell |
-7,817
| Closed | -$26K | – | 1725 |
|
|
2015
Q1 | $26K | Buy |
7,817
+150
| +2% | +$499 | ﹤0.01% | 2488 |
|
|
2014
Q4 | $27K | Hold |
7,667
| – | – | ﹤0.01% | 2411 |
|
|
2014
Q3 | $39K | Hold |
7,667
| – | – | ﹤0.01% | 2071 |
|
|
2014
Q2 | $106K | Hold |
7,667
| – | – | ﹤0.01% | 1386 |
|
|
2014
Q1 | $117K | Hold |
7,667
| – | – | ﹤0.01% | 1296 |
|
|
2013
Q4 | $62K | Hold |
7,667
| – | – | ﹤0.01% | 1459 |
|
|
2013
Q3 | $76K | Hold |
7,667
| – | – | ﹤0.01% | 1282 |
|
|
2013
Q2 | $33K | Buy |
+7,667
| New | +$33K | ﹤0.01% | 1614 |
|